Sinjard-L Tablet 25 mg+5 mg is a combination oral antidiabetic medication containing Empagliflozin and Linagliptin. It is specifically formulated to provide comprehensive glycemic control in adults with type 2 diabetes mellitus. By combining two complementary mechanisms, this medication helps lower blood glucose levels effectively and consistently. It is particularly useful for patients who require stronger glucose control when single-agent therapy is insufficient.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Empagliflozin 25 mg
• Linagliptin 5 mg

Mechanism of Action

Sinjard-L Tablet works through dual pathways to regulate blood glucose:

• Empagliflozin: A sodium-glucose co-transporter 2 (SGLT2) inhibitor that reduces glucose reabsorption in the kidneys, increasing urinary glucose excretion and lowering blood sugar levels.
• Linagliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances incretin hormone activity, promoting insulin secretion and reducing glucagon levels in a glucose-dependent manner.

This combination ensures improved glycemic control without significantly increasing the risk of hypoglycemia.

Indications

Sinjard-L Tablet 25 mg+5 mg is indicated for:

• Management of type 2 diabetes mellitus in adults
• Patients inadequately controlled with monotherapy or lower-dose combination therapy
• Improving overall blood glucose control alongside diet and exercise

Dosage and Administration

• The recommended dose is one tablet once daily or as prescribed by a physician.
• Can be taken with or without food.
• Preferably taken at the same time each day for consistent effect.
• Maintain adequate hydration during treatment.

Benefits

• Dual-action mechanism for enhanced glucose lowering
• Convenient once-daily dosing
• Low risk of hypoglycemia when used appropriately
• Supports weight management through glucose excretion
• May provide cardiovascular and renal benefits

Side Effects

Common side effects may include:

• Increased urination
• Urinary tract infections
• Nasopharyngitis
• Headache
• Genital fungal infections

Rare but serious side effects include pancreatitis, ketoacidosis, severe dehydration, or allergic reactions. Immediate medical attention is required if severe symptoms develop.

Precautions and Warnings

• Not suitable for patients with type 1 diabetes or diabetic ketoacidosis.
• Use cautiously in patients with kidney or liver impairment.
• Monitor blood glucose and renal function regularly.
• Ensure proper hydration to avoid dehydration-related complications.
• Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Drug Interactions

Sinjard-L Tablet may interact with:

• Other antidiabetic drugs (risk of hypoglycemia)
• Diuretics (increased risk of dehydration)
• Enzyme inducers or inhibitors affecting drug metabolism

Always consult your healthcare provider before combining with other medications.

Storage

• Store below 30°C in a cool, dry place
• Protect from light and moisture
• Keep out of reach of children.